The DOI matches its Crossref record; 262 of the 262 references it cites were found in a registry or an index.
Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Lacroix, M., Abi-Said, D., Fourney, D. R., Gokaslan, Z. L., Shi, W., DeMonte, F., Lang, F. F., McCutcheon, I. E., Hassenbusch, S. J., Holland, E., et al. (2001) · Journal of Neurosurgery · doi:10.3171/jns.2001.95.2.0190 · Cited by 3,091
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,973
Modes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953 · cited 4×
“derived cells (BMDCs) that have the capacity to increase tumor growth through new blood vessel growth [63].”
BackgroundInfluentialProgenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P., & Gurtner, G. C. (2004) · Nature Medicine · doi:10.1038/nm1075 · Cited by 2,600
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
(1999) · PubMed · Cited by 2,204
Marciniak, S. J., Yun, C. Y., Oyadomari, S., Novoa, I., Zhang, Y., Jungreis, R., Nagata, K., Harding, H. P., & Ron, D. (2004) · Genes & Development · doi:10.1101/gad.1250704 · Cited by 2,001
Regulation of Mammalian O 2 Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.551 · Cited by 1,914
Höckel, M., Schlenger, K., Aral, B., Mitze, M., Schäffer, U., & Vaupel, P. W. (1996) · PubMed · Cited by 1,727
Helmlinger, G., Yuan, F., Dellian, M., & Jain, R. K. (1997) · Nature Medicine · doi:10.1038/nm0297-177 · Cited by 1,628
HIF‐1α is required for solid tumor formation and embryonic vascularization
Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579
Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Lando, D., Peet, D. J., Gorman, J. J., Whelan, D. A., Whitelaw, M. L., & Bruick, R. K. (2002) · Genes & Development · doi:10.1101/gad.991402 · Cited by 1,550
Hypoxia-inducible expression of tumor-associated carbonic anhydrases.
Wykoff, C. C., Beasley, N. J. P., Watson, P. H., Turner, K., Pastorek, J., Sibtain, A., Wilson, G. D., Turley, H., Talks, K., Maxwell, P. H., et al. (2000) · PubMed · Cited by 1,491
Mahon, P. C., Hirota, K., & Semenza, G. L. (2001) · Genes & Development · doi:10.1101/gad.924501 · Cited by 1,385
Determinants of tumor blood flow: a review.
Jain, R. K. (1988) · PubMed · Cited by 1,379
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene
Pennacchietti, S., Michieli, P., Galluzzo, M., Mazzone, M., Giordano, S., & Comoglio, P. M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00085-0 · Cited by 1,311
Jiang, B. H., Semenza, G. L., Bauer, C., & Marti, H. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.4.c1172 · Cited by 1,213
Du, R., Lu, K. V., Petritsch, C., Liu, P., Ganss, R., Passegué, E., Song, H., VandenBerg, S., Johnson, R. S., Werb, Z., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.034 · Cited by 1,130
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
Brandsma, D., Stalpers, L., Taal, W., Sminia, P., & van den Bent, M. J. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70125-6 · Cited by 1,121
Dimerization, DNA Binding, and Transactivation Properties of Hypoxia-inducible Factor 1
Jiang, B.-H., Rue, E., Wang, G. L., Roe, R., & Semenza, G. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17771 · Cited by 1,106 · cited 1×
“However, at the posttranscriptional level, HIF-1a protein is tightly regulated by two independent mechanisms [76].”
BackgroundMaxwell, P. H., Dachs, G. U., Gleadle, J. M., Nicholls, L. G., Harris, A. L., Stratford, I. J., Hankinson, O., Pugh, C. W., & Ratcliffe, P. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8104 · Cited by 1,084
Cockman, M. E., Masson, N., Mole, D. R., Jaakkola, P., Chang, G.-W., Clifford, S. C., Maher, E. R., Pugh, C. W., Ratcliffe, P. J., & Maxwell, P. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002740200 · Cited by 1,050
Imaging of angiogenesis: from microscope to clinic
McDonald, D. M., & Choyke, P. L. (2003) · Nature Medicine · doi:10.1038/nm0603-713 · Cited by 1,016
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
Iliopoulos, O., Levy, A. P., Jiang, C., Kaelin, W. G., & Goldberg, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10595 · Cited by 892
Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth.
Ryan, H. E., Poloni, M., McNulty, W., Elson, D., Gassmann, M., Arbeit, J. M., & Johnson, R. S. (2000) · PubMed · Cited by 890
Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL
Staller, P., Sulitkova, J., Lisztwan, J., Moch, H., Oakeley, E. J., & Krek, W. (2003) · Nature · doi:10.1038/nature01874 · Cited by 870
Molecular basis of the VHL hereditary cancer syndrome
Kaelin, W. G. (2002) · Nature Reviews Cancer · doi:10.1038/nrc885 · Cited by 865
Signal transduction to hypoxia-inducible factor 1
Semenza, G. L. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01168-1 · Cited by 860
Walenta, S., Wetterling, M., Lehrke, M., Schwickert, G., Sundfør, K., Rofstad, E. K., & Mueller‐Klieser, W. (2000) · PubMed · Cited by 850
Loss of PTEN facilitates HIF-1-mediated gene expression
Zundel, W., Schindler, C., Haas-Kogan, D., Koong, A., Kaper, F., Chen, E., Gottschalk, A. R., Ryan, H. E., Johnson, R. S., Jefferson, A. B., et al. (2000) · Genes & Development · doi:10.1101/gad.14.4.391 · Cited by 840
Brandes, A. A., Franceschi, E., Tosoni, A., Blatt, V., Pession, A., Tallini, G., Bertorelle, R., Bartolini, S., Calbucci, F., Andreoli, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.8163 · Cited by 840
Gatenby, R. A., Kessler, H. B., Rosenblum, J. S., Coia, L. R., Moldofsky, P. J., Hartz, W. H., & Broder, G. J. (1988) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(88)90002-8 · Cited by 798
Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2.
Feldser, D. M., Agani, F. H., Iyer, N. V., Pak, B. J., Ferreira, G., & Semenza, G. L. (1999) · PubMed · Cited by 782
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
Kondo, K., Klco, J., Nakamura, E., Lechpammer, M., & Kaelin, W. G. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00043-0 · Cited by 761
Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and Angiogenesis
Eyler, C. E., & Rich, J. N. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.1829 · Cited by 737
2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF
Mabjeesh, N. J., Escuin, D., LaVallee, T. M., Pribluda, V. S., Swartz, G. M., Johnson, M. S., Willard, M. T., Zhong, H., Simons, J. W., & Giannakakou, P. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00077-1 · Cited by 730
ER stress‐regulated translation increases tolerance to extreme hypoxia and promotes tumor growth
Bi, M., Naczki, C., Koritzinsky, M., Fels, D., Blais, J., Hu, N., Harding, H., Novoa, I., Varia, M., Raleigh, J., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600777 · Cited by 729
Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis
Kaur, B., Khwaja, F. W., Severson, E. A., Matheny, S. L., Brat, D. J., & Van Meir, E. G. (2005) · Neuro-Oncology · doi:10.1215/s1152851704001115 · Cited by 725 · cited 1×
“Although less is known about human brain tumors, it is stands to reason that hypoxia may play a similar role in these tumors [20, 21], especially the highly aggressive GBM [22].”
BackgroundHewitson, K. S., McNeill, L. A., Riordan, M. V., Tian, Y.-M., Bullock, A. N., Welford, R. W., Elkins, J. M., Oldham, N. J., Bhattacharya, S., Gleadle, J. M., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200273200 · Cited by 719
(2000) · PubMed · Cited by 614
(2001) · PubMed · Cited by 605
Zagzag, D., Zhong, H., Scalzitti, J. M., Laughner, E., Simons, J. W., & Semenza, G. L. (2000) · Cancer · doi:10.1002/1097-0142(20000601)88:11<2606::aid-cncr25>3.0.co;2-w · Cited by 604
The SDF-1–CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis
Petit, I., Jin, D., & Rafii, S. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.05.007 · Cited by 603
Glial Neoplasms: Dynamic Contrast-enhanced T2*-weighted MR Imaging
Knopp, E. A., Cha, S., Johnson, G., Mazumdar, A., Golfinos, J. G., Zagzag, D., Miller, D. C., Kelly, P. J., & Kricheff, I. I. (1999) · Radiology · doi:10.1148/radiology.211.3.r99jn46791 · Cited by 596
Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis
Bos, R., Zhong, H., Hanrahan, C. F., Mommers, E. C. M., Semenza, G. L., Pinedo, H. M., Abeloff, M. D., Simons, J. W., van Diest, P. J., & van der Wall, E. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.309 · Cited by 593
Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha /ARNT
Zelzer, E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5085 · Cited by 575
Rong, Y., Durden, D. L., Van Meir, E. G., & Brat, D. J. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-200606000-00001 · Cited by 567
Rasey, J. S., Koh, W.-J., Evans, M. L., Peterson, L. M., Lewellen, T. K., Graham, M. M., & Krohn, K. A. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00325-2 · Cited by 562
Gnarra, J. R., Zhou, S., Merrill, M. J., Wagner, J. R., Krumm, A., Papavassiliou, E., Oldfield, E. H., Klausner, R. D., & Linehan, W. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10589 · Cited by 531
De Falco, E., Porcelli, D., Torella, A. R., Straino, S., Iachininoto, M. G., Orlandi, A., Truffa, S., Biglioli, P., Napolitano, M., Capogrossi, M. C., et al. (2004) · Blood · doi:10.1182/blood-2003-12-4423 · Cited by 521
Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity.
Kong, D., Park, E. J., Stephen, A. G., Calvani, M., Cardellina, J. H., Monks, A., Fisher, R. J., Shoemaker, R. H., & Melillo, G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1235 · Cited by 508 · cited 8×
“Using similar methods, we have been working on developing HRE-controlled expression of short hairpin vector-expressing inhibitory RNA for specific posttran- scriptional gene silencing (Fig.”
BackgroundInfluentialIwai, K., Yamanaka, K., Kamura, T., Minato, N., Conaway, R. C., Conaway, J. W., Klausner, R. D., & Pause, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12436 · Cited by 508
Mazure, N. M., Chen, E. Y., Laderoute, K. R., & Giaccia, A. J. (1997) · Blood · doi:10.1182/blood.v90.9.3322 · Cited by 503
Bos, R., van der Groep, P., Greijer, A. E., Shvarts, A., Meijer, S., Pinedo, H. M., Semenza, G. L., van Diest, P. J., & van der Wall, E. (2003) · Cancer · doi:10.1002/cncr.11246 · Cited by 500
Richard, D. E., Berra, E., & Pouysségur, J. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61441-9 · Cited by 488
Brat, D. J., Castellano-Sanchez, A. A., Hunter, S. B., Pecot, M., Cohen, C., Hammond, E. H., Devi, S. N., Kaur, B., & Van Meir, E. G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2073 · Cited by 485
Loncaster, J. A., Harris, A. L., Davidson, S. E., Logue, J. P., Hunter, R. D., Wycoff, C. C., Pastorek, J., Ratcliffe, P. J., Stratford, I. J., & West, C. (2001) · PubMed · Cited by 482
Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential.
Fujibayashi, Y., Taniuchi, H., Yonekura, Y., Ohtani, H., Konishi, J., & Yokoyama, A. (1997) · PubMed · Cited by 481
Mammalian class theta GST and differential susceptibility to carcinogens: a review
Landi, S. (2000) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(00)00050-8 · Cited by 477
Taal, W., Brandsma, D., de Bruin, H. G., Bromberg, J. E., Swaak‐Kragten, A. T., Sillevis Smitt, P. A. E., van Es, C. A., & van den Bent, M. J. (2008) · Cancer · doi:10.1002/cncr.23562 · Cited by 465
Kimura, H., Weisz, A., Kurashima, Y., Hashimoto, K., Ogura, T., D'Acquisto, F., Addeo, R., Makuuchi, M., & Esumi, H. (2000) · Blood · doi:10.1182/blood.v95.1.189 · Cited by 439
Tajiri, S., Oyadomari, S., Yano, S., Morioka, M., Gotoh, T., Hamada, J.-I., Ushio, Y., & Mori, M. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401365 · Cited by 428
Möller-Hartmann, W., Herminghaus, S., Krings, T., Marquardt, G., Lanfermann, H., Pilatus, U., & Zanella, F. (2002) · Neuroradiology · doi:10.1007/s00234-001-0760-0 · Cited by 406
Akakura, N., Kobayashi, M., Horiuchi, I., Suzuki, A., Wang, J., Chen, J., Niizeki, H., Ki, K., Hosokawa, M., & Asaka, M. (2001) · PubMed · Cited by 400
Jögi, A., Øra, I., Nilsson, H., Lindeheim, Å., Makino, Y., Poellinger, L., Axelson, H., & Påhlman, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102660199 · Cited by 399
Krieg, M., Haas, R., Brauch, H., Acker, T., Flamme, I., & Plate, K. H. (2000) · Oncogene · doi:10.1038/sj.onc.1203938 · Cited by 396 · cited 1×
“Furthermore, constitutive expression of HIF-1a has been detected in cancer cells related to VHL disease [95, 96, 98].”
BackgroundZagzag, D., Lukyanov, Y., Lan, L., Ali, M. A., Esencay, M., Mendez, O., Yee, H., Voura, E. B., & Newcomb, E. W. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700482 · Cited by 396
Fibrous sheath of mammalian spermatozoa
Eddy, E. M., Toshimori, K., & O'Brien, D. A. (2003) · Microscopy Research and Technique · doi:10.1002/jemt.10320 · Cited by 383
Mechanisms of Chemoresistance to Alkylating Agents in Malignant Glioma
Sarkaria, J. N., Kitange, G. J., James, C. D., Plummer, R., Calvert, H., Weller, M., & Wick, W. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1719 · Cited by 373
Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model.
Lewis, J. S., Mccarthy, D. W., McCarthy, T. J., Fujibayashi, Y., & Welch, M. J. (1999) · PubMed · Cited by 357
Carroll, V. A., & Ashcroft, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2519 · Cited by 352
Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma
Chamberlain, M. C., Glantz, M. J., Chalmers, L., Van Horn, A., & Sloan, A. E. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9241-y · Cited by 343
Mabjeesh, N. J., Post, D. E., Willard, M. T., Kaur, B., Meir, E. G. V., Simons, J. W., & Zhong, H. (2002) · PubMed · Cited by 338
Dehdashti, F., Grigsby, P. W., Mintun, M. A., Lewis, J. S., Siegel, B. A., & Welch, M. J. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04477-2 · Cited by 326
Transcriptional Response to Hypoxia in Human Tumors
Lal, A., Peters, H., St. Croix, B., Haroon, Z. A., Dewhirst, M. W., Strausberg, R. L., Kaanders, J. H. A. M., van der Kogel, A. J., & Riggins, G. J. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.17.1337 · Cited by 320
Siemeister, G., Weindel, K., Mohrs, K., Barleon, B., Martiny‐Baron, G., & Marmé, D. (1996) · PubMed · Cited by 308
Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors
Rampling, R., Cruickshank, G., Lewis, A. D., Fitzsimmons, S. A., & Workman, P. (1994) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)90432-4 · Cited by 304
Raleigh, J. A., Chou, S.-C., Arteel, G. E., & Horsman, M. R. (1999) · Radiation Research · doi:10.2307/3580034 · Cited by 304
Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer
Potter, C. P. S., & Harris, A. L. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600936 · Cited by 300
Sutter, C. H., Laughner, E., & Semenza, G. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080072497 · Cited by 299
Li, J.-L., Sainson, R. C. A., Shi, W., Leek, R., Harrington, L. S., Preusser, M., Biswas, S., Turley, H., Heikamp, E., Hainfellner, J. A., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0969 · Cited by 299
(2002) · PubMed · Cited by 296
Angiogenesis: How a Tumor Adapts to Hypoxia
Richard, D. E., Berra, E., & Pouysségur, J. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1889 · Cited by 280
Spence, A. M., Muzi, M., Swanson, K. R., O'Sullivan, F., Rockhill, J. K., Rajendran, J. G., Adamsen, T. C. H., Link, J. M., Swanson, P. E., Yagle, K. J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4995 · Cited by 277
Daldrup, H., Shames, D. M., Wendland, M., Okuhata, Y., Link, T. M., Rosenau, W., Lu, Y., & Brasch, R. C. (1998) · American Journal of Roentgenology · doi:10.2214/ajr.171.4.9762973 · Cited by 268
Wykoff, C. C., Pugh, C. W., Maxwell, P. H., Harris, A. L., & Ratcliffe, P. J. (2000) · Oncogene · doi:10.1038/sj.onc.1204012 · Cited by 266
Development of a hypoxia-responsive vector for tumor-specific gene therapy
Shibata, T., Giaccia, A. J., & Brown, J. M. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301124 · Cited by 266
Prognostic significance of preoperative MRI scans in glioblastoma multiforme
Hammoud, M. A., Sawaya, R., Shi, W., Thall, P. F., & Leeds, N. E. (1996) · Journal of Neuro-Oncology · doi:10.1007/bf00146086 · Cited by 263
Sathornsumetee, S., Cao, Y., Marcello, J. E., Herndon, J. E., McLendon, R. E., Desjardins, A., Friedman, H. S., Dewhirst, M. W., Vredenburgh, J. J., & Rich, J. N. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.3652 · Cited by 261
Blazek, E. R., Foutch, J. L., & Maki, G. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.09.037 · Cited by 259
Von Hippel-Lindau Syndrome: A pleomorphic condition
Friedrich, C. A. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991201)86:11+<2478::aid-cncr4>3.0.co;2-5 · Cited by 258
Tumor tissue oxygenation as evaluated by computerized-po2-histography
Kallinowski, F., Zander, R., Hoeckel, M., & Vaupel, P. (1990) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(90)90018-f · Cited by 253
Assessing tumor angiogenesis using macromolecular MR imaging contrast media
Brasch, R., Pham, C., Shames, D., Roberts, T., Van Dijke, K., Van Bruggen, N., Mann, J., Ostrowitzki, S., & Melnyk, O. (1997) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880070110 · Cited by 250
Rice, G. C., Hoy, C., & Schimke, R. T. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.16.5978 · Cited by 249
A RNA antagonist of hypoxia-inducible factor-1α, EZN-2968, inhibits tumor cell growth
Greenberger, L. M., Horak, I. D., Filpula, D., Sapra, P., Westergaard, M., Frydenlund, H. F., Albæk, C., Schrøder, H., & Ørum, H. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0510 · Cited by 245 · cited 1×
“Small molecule antagonists of HIF-1 inhibit also inhibit GBM growth (Table 2) [248, 249].”
BackgroundPTEN and Hypoxia Regulate Tissue Factor Expression and Plasma Coagulation by Glioblastoma
Rong, Y., Post, D. E., Pieper, R. O., Durden, D. L., Van Meir, E. G., & Brat, D. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3376 · Cited by 239
Oncogenes as inducers of tumor angiogenesis
Rak, J., Filmus, J., Finkenzeller, G., Grugel, S., Marm�, D., & Kerbel, R. S. (1995) · Cancer and Metastasis Reviews · doi:10.1007/bf00690598 · Cited by 235
Identification of a Novel Small-Molecule Inhibitor of the Hypoxia-Inducible Factor 1 Pathway
Tan, C., de Noronha, R. G., Roecker, A. J., Pyrzynska, B., Khwaja, F., Zhang, Z., Zhang, H., Teng, Q., Nicholson, A. C., Giannakakou, P., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.605.65.2 · Cited by 225
Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole.
Valk, P. E., Mathis, C. A., Prados, M. D., Gilbert, J. C., & Budinger, T. F. (1992) · PubMed · Cited by 224
Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts.
Lord, E. M., Harwell, L. W., & Koch, C. J. (1993) · PubMed · Cited by 223
Airley, R. E., Loncaster, J., Raleigh, J. A., Harris, A. L., Davidson, S. E., Hunter, R. D., West, C. M. L., & Stratford, I. J. (2003) · International Journal of Cancer · doi:10.1002/ijc.10904 · Cited by 221
Carrière, A., Carmona, M.-C., Fernandez, Y., Rigoulet, M., Wenger, R. H., Pénicaud, L., & Casteilla, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407258200 · Cited by 220
Zagzag, D., Esencay, M., Mendez, O., Yee, H., Smirnova, I., Huang, Y., Chiriboga, L., Lukyanov, E., Liu, M., & Newcomb, E. W. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.071197 · Cited by 216
Bruehlmeier, M., Roelcke, U., Schubiger, P. A., & Ametamey, S. M. (2004) · PubMed · Cited by 214
The VHL tumour-suppressor gene paradigm
Kaelin, W. G., & Maher, E. R. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(98)01558-3 · Cited by 213
Pham, C. D., Roberts, T. P. L., Van Bruggen, N., Melnyk, O., Mann, J., Ferrara, N., Cohen, R. L., & Brasch, R. C. (1998) · Cancer Investigation · doi:10.3109/07357909809039771 · Cited by 208
(2000) · PubMed · Cited by 206
Deal, C., Ma, J., Wilkin, F., Paquette, J., Rozen, F., Ge, B., Hudson, T., Stampfer, M., & Pollak, M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7280 · Cited by 206
Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer.
Olive, P. L., Aquino‐Parsons, C., MacPhail, S. H., Liao, S. Y., Raleigh, J. A., Lerman, M. I., & Stanbridge, E. J. (2001) · PubMed · Cited by 206
Insulin-Like Growth Factor Binding Proteins: New Proteins, New Functions
Ferry Jr., R. J., Cerri, R. W., & Cohen, P. (1999) · Hormone Research in Paediatrics · doi:10.1159/000023315 · Cited by 205
Rischin, D., Peters, L., Hicks, R., Hughes, P., Fisher, R., Hart, R., Sexton, M., D’Costa, I., & von Roemeling, R. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.535 · Cited by 201
Leek, R., Talks, K., Pezzella, F., Turley, H., Campo, L., Brown, N. S., Bicknell, R., Taylor, M., Gatter, K. C., & Harris, A. L. (2002) · PubMed · Cited by 199
Martínez-Gac, L., Marqués, M., García, Z., Campanero, M. R., & Carrera, A. C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.5.2181-2189.2004 · Cited by 193
Graham, C. H., Forsdike, J., Fitzgerald, C. J., & Macdonald-Goodfellow, S. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990209)80:4<617::aid-ijc22>3.0.co;2-c · Cited by 192
Lewis, J. S., Sharp, T. L., Laforest, R. A., Fujibayashi, Y., & Welch, M. J. (2001) · PubMed · Cited by 187
Sundfør, K., Lyng, H., & Rofstad, E. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.586 · Cited by 186
A tiger behind many doors: multiple genetic pathways to malignant glioma
Louis, D. N., & Gusella, J. F. (1995) · Trends in Genetics · doi:10.1016/s0168-9525(00)89125-8 · Cited by 185
Distribution of the glucose transporters in human brain tumors.
Nishioka, T., Oda, Y., Seino, Y., Yamamoto, T., Inagaki, N., Yano, H., Imura, H., Shigemoto, R., & Kikuchi, H. (1992) · PubMed · doi:10.11501/3066169 · Cited by 184
Tacchini, L. (2001) · Carcinogenesis · doi:10.1093/carcin/22.9.1363 · Cited by 180
Brandes, A. A., Tosoni, A., Franceschi, E., Reni, M., Gatta, G., & Vecht, C. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.02.005 · Cited by 178
Arteel, G. E., Thurman, R. G., & Raleigh, J. A. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2530743.x · Cited by 176
Aghi, M., Cohen, K. S., Klein, R. J., Scadden, D. T., & Chiocca, E. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3759 · Cited by 175
Hypoxic stress proteins: Survival of the fittest
Giaccia, A. J. (1996) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(96)80035-x · Cited by 172
Cuvier, C., Jang, A., & Hill, R. P. (1997) · Clinical & Experimental Metastasis · doi:10.1023/a:1018428105463 · Cited by 169
Establishing a Link between Oncogenes and Tumor Angiogenesis
Kerbel, R. S., Viloria‐Petit, A., Okada, F., & Rak, J. W. (1998) · Molecular Medicine · doi:10.1007/bf03401737 · Cited by 168
De Wit, D., Olislagers, V., Goriely, S., Vermeulen, F., Wagner, H., Goldman, M., & Willems, F. (2004) · Blood · doi:10.1182/blood-2003-04-1216 · Cited by 168
Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors
Boado, R. J., Black, K. L., & Pardridge, W. M. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90183-x · Cited by 168
Vascular Microenvironment in Gliomas
Vajkoczy, P., & Menger, M. D. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1006474832189 · Cited by 167
Necrosis and Glioblastoma: A Friend or a Foe? A Review and a Hypothesis
Raza, S. M., Lang, F. F., Aggarwal, B. B., Fuller, G. N., Wildrick, D. M., & Sawaya, R. (2002) · Neurosurgery · doi:10.1097/00006123-200207000-00002 · Cited by 167
Patel, S. J., Shapiro, W. R., Laske, D. W., Jensen, R. L., Asher, A. L., Wessels, B. W., Carpenter, S. P., & Shan, J. S. (2005) · Neurosurgery · doi:10.1227/01.neu.0000159649.71890.30 · Cited by 166
Self-citationCollingridge, D. R., Piepmeier, J. M., Rockwell, S., & Knisely, J. P. S. (1999) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00121-8 · Cited by 164
Chau, N., Rogers, P., Aherne, W., Carroll, V. A., Collins, I., McDonald, E., Workman, P., & Ashcroft, M. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4453 · Cited by 164
Tumor hypoxia in pelvic recurrences of cervical cancer
Höckel, M., Schlenger, K., Höckel, S., Aral, B., Schäffer, U., & Vaupel, P. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980821)79:4<365::aid-ijc10>3.0.co;2-4 · Cited by 162
Hypoxia: the tumor's gateway to progression along the angiogenic pathway
Brahimi‐Horn, C., Berra, E., & Pouysségur, J. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02126-2 · Cited by 153
Genotype-phenotype correlation in von Hippel-Lindau syndrome
Friedrich, C. A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.763 · Cited by 150
A novel hypoxia-inducible factor (HIF) activated oncolytic adenovirus for cancer therapy
Post, D. E., & Meir, E. G. V. (2003) · Oncogene · doi:10.1038/sj.onc.1206464 · Cited by 147
Davare, M. A., Dong, F., Rubin, C. S., & Hell, J. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30280 · Cited by 147
Deal, C. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1274 · Cited by 146
Tabatabai, G., Frank, B., Möhle, R., Weller, M., & Wick, W. (2006) · Brain · doi:10.1093/brain/awl173 · Cited by 144
Flynn, J. R., Wang, L., Gillespie, D. L., Stoddard, G. J., Reid, J. K., Owens, J., Ellsworth, G. B., Salzman, K. L., Kinney, A. Y., & Jensen, R. L. (2008) · Cancer · doi:10.1002/cncr.23678 · Cited by 143
Self-citationAlbertella, M. R., Loadman, P. M., Jones, P. H., Phillips, R. M., Rampling, R., Burnet, N. G., Alcock, C., Anthoney, A., Vjaters, E., Dunk, C. R., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4020 · Cited by 143
Rijken, P. F. J. W., Bernsen, H. J. J. A., Peters, J. P. W., Hodgkiss, R. J., Raleigh, J. A., & van der Kogel, A. J. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00686-6 · Cited by 142
Hypoxia can induce c‐Met expression in glioma cells and enhance SF/HGF‐induced cell migration
Eckerich, C., Zapf, S., Fillbrandt, R., Loges, S., Westphal, M., & Lamszus, K. (2007) · International Journal of Cancer · doi:10.1002/ijc.22679 · Cited by 139
Obata, A., Yoshimi, E., Waki, A., Lewis, J. S., Oyama, N., Welch, M. J., Saji, H., Yonekura, Y., & Fujibayashi, Y. (2001) · Annals of Nuclear Medicine · doi:10.1007/bf02988502 · Cited by 139
Fujiwara, K., Iwado, E., Mills, G. B., Sawaya, R. A., Kondo, S., & Kondo, Y. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.4.753 · Cited by 139
Pathak, A. P., Schmainda, K. M., Ward, B. D., Linderman, J. R., Rebro, K. J., & Greene, A. S. (2001) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1252 · Cited by 135
Evaluation of malignant glioma patients during the postirradiation period
Hoffman, W. F., Levin, V. A., & Wilson, C. B. (1979) · Journal of neurosurgery · doi:10.3171/jns.1979.50.5.0624 · Cited by 133
Essential roles of IGFBP-3 and IGFBP-rP1 in breast cancer
Burger, A. M., Leyland-Jones, B. R., Banerjee, K., Spyropoulos, D. D., & Seth, A. K. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.023 · Cited by 132
Zou, G.-M., & Maitra, A. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0113 · Cited by 131
Glucose transporter-1 (GLUT-1): a potential marker of prognosis in rectal carcinoma?
Cooper, R., Sarıoğlu, S., Sökmen, S., Füzün, M., Küpelioğlu, A., Valentine, H. R., Görken, İ. B., Airley, R. E., & West, C. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601202 · Cited by 130
Fung, K.-M., Samara, E. N. S., Wong, C., Metwalli, A., Krlin, R., Bane, B., Liu, C. Z., Yang, J. T., Pitha, J. V., Culkin, D. J., et al. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01048 · Cited by 129
Malignant Glioma Physiology: Cellular Response to Hypoxia and Its Role in Tumor Progression
Brat, D. J., & Mapstone, T. B. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-8-200304150-00014 · Cited by 128
Aldo-keto reductase (AKR) 1C3: Role in prostate disease and the development of specific inhibitors
Penning, T. M., Steckelbroeck, S., Bauman, D. R., Miller, M. W., Jin, Y., Peehl, D. M., Fung, K.-M. A., & Lin, H.-K. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.12.009 · Cited by 127
Characterisation of human cyclin G1 and G2: DNA damage inducible genes.
Bates, S. E., Rowan, S., & Vousden, K. H. (1996) · PubMed · Cited by 126
Griffiths, J. R., Taylor, N. J., Howe, F. A., Saunders, M. I., Robinson, S. P., Hoskin, P., Powell, M. E. B., Thoumine, M., Caine, L. A., & Baddeley, H. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00326-x · Cited by 125
Tumor Hypoxia and Gene Expression: Implications for Malignant Progression and Therapy
Sutherland, R. M. (1998) · Acta Oncologica · doi:10.1080/028418698430278 · Cited by 122
Imaging tumor hypoxia and tumor perfusion.
Groshar, D., McEwan, A. J. B., Parliament, M. B., Urtasun, R. C., Golberg, L. E., Hoskinson, M., Mercer, J. R., Mannan, R., Wiebe, L. I., & Chapman, J. D. (1993) · PubMed · Cited by 121
Abramovitch, R., Dafni, H., Smouha, E., Benjamin, L. E., & Neeman, M. (1999) · PubMed · Cited by 121
Zagzag, D., Nomura, M., Friedlander, D. R., Blanco, C., Gagner, J., Nomura, N., & Newcomb, E. W. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10306 · Cited by 120
Bentzen, L., Keiding, S., Nordsmark, M., Falborg, L., Hansen, S. B., Keller, J. O., Nielsen, O. S., & Overgaard, J. (2003) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(03)00081-1 · Cited by 118
Post, D., & Meir, E. G. V. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301605 · Cited by 118
Bhujwalla, Z. M., Artemov, D., Natarajan, K., Ackerstaff, E., & Solaiyappan, M. (2001) · Neoplasia · doi:10.1038/sj.neo.7900129 · Cited by 117
Intratumoral oxygen pressure in malignant brain tumor
Kayama, T., Yoshimoto, T., Fujimoto, S., & Sakurai, Y. (1991) · Journal of neurosurgery · doi:10.3171/jns.1991.74.1.0055 · Cited by 116
The Role of Radio- and Chemotherapy in Glioblastoma
Stupp, R., & Weber, D. C. (2005) · Oncology Research and Treatment · doi:10.1159/000085575 · Cited by 113
Jones, A., Fujiyama, C., Blanche, C., Moore, J. W., Fuggle, S., Cranston, D., Bicknell, R., & Harris, A. L. (2001) · PubMed · Cited by 110
Span, P. N., Bussink, J., Manders, P., Beex, L. V. A. M., & Sweep, F. C. G. J. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601122 · Cited by 109
Suppression of growth of renal carcinoma cells by the von Hippel-Lindau tumor suppressor gene.
Chen, F., Kishida, T., Duh, F.-M. C., Renbaum, P., Orcutt, M. L., Schmidt, L. S., & Zbar, B. (1995) · PubMed · Cited by 108
Ihnatko, R., Kubeš, M., Takáčová, M., Sedlakova, O., Sedlák, J., Pastorek, J., Kopáček, J., & Pastoreková, S. (2006) · International Journal of Oncology · doi:10.3892/ijo.29.4.1025 · Cited by 108
Chen, Z., Htay, A., dos Santos, W. G., Gillies, G. T., Fillmore, H. L., Sholley, M. M., & Broaddus, W. C. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9742-y · Cited by 108
New insights into 2-methoxyestradiol, a promising antiangiogenic and antitumor agent
Mooberry, S. L. (2003) · Current Opinion in Oncology · doi:10.1097/00001622-200311000-00004 · Cited by 106
Seimiya, H., Tanji, M., Oh‐hara, T., Tomida, A., Naasani, I., & Tsuruo, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0910 · Cited by 105
Huang, X., Wang, J., Huang, C., Chen, Y., Shi, G., Hu, Q.-S., & Yi, J. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.3.5457 · Cited by 103
Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance
Sakata, K., Kwok, T. T., Murphy, B. J., Laderoute, K. R., Gordon, G. R., & Sutherland, R. J. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.405 · Cited by 103
Rong, Y., Hu, F., Huang, R.-P., Mackman, N., Horowitz, J. M., Jensen, R. L., Durden, D. L., Meir, E. G. V., & Brat, D. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0346 · Cited by 102
Self-citationGillespie, D. L., Whang, K., Ragel, B. T., Flynn, J. R., Kelly, D. A., & Jensen, R. L. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2692 · Cited by 101
Self-citationHypoxia Causes Downregulation of Mismatch Repair System and Genomic Instability in Stem Cells
Rodríguez-Jiménez, F. J., Moreno‐Manzano, V., Lucas-Domínguez, R., & Sánchez-Puelles, J.-M. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1016 · Cited by 99
A dominant-negative isoform lacking exons 11 and 12 of the human hypoxia-inducible factor-1α gene
Chun, Y., Choi, E., Kim, T., Kim, M.-S., & Park, J. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3620071 · Cited by 96
Characterization of [18F]fluoroetanidazole, a new radiopharmaceutical for detecting tumor hypoxia.
Rasey, J. S., Hofstrand, P. D., Chin, L. K., & Tewson, T. J. (1999) · PubMed · Cited by 94
Shibata, T., Akiyama, N., Noda, M., Sasai, K., & Hiraoka, M. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00298-3 · Cited by 94
Burton, T. R., Henson, E. S., Baijal, P. K., Eisenstat, D. D., & Gibson, S. B. (2005) · International Journal of Cancer · doi:10.1002/ijc.21547 · Cited by 92
Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas
Wijffels, K. I. E. M., Kaanders, J. H. A. M., Rijken, P. F. J. W., Bussink, J., van den Hoogen, F. J. A., Marres, H. A. M., de Wilde, P. C. M., Raleigh, J. A., & van der Kogel, A. J. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1325 · Cited by 92
A Hypoxia-Regulated Adeno-Associated Virus Vector for Cancer-Specific Gene Therapy
Ruan, H., Sutt, H., Hu, L. J., Lamborn, K. R., Kan, Y. W., & Deen, D. F. (2001) · Neoplasia · doi:10.1038/sj.neo.7900157 · Cited by 91
Parney, I. F., Kunwar, S., McDermott, M., Berger, M. S., Prados, M. D., Cha, S., Croteau, D. J., Puri, R. K., & Chang, S. M. (2005) · Journal of neurosurgery · doi:10.3171/jns.2005.102.2.0267 · Cited by 91
Hypoxia-inducible factor-1alpha is an intrinsic marker for hypoxia in cervical cancer xenografts.
Vukovic, V. M., Haugland, H. K., Nicklee, T., Morrison, A. J., & Hedley, D. W. (2001) · PubMed · Cited by 90
Genetic modulation of hypoxia induced gene expression and angiogenesis relevance to brain tumors
Brat, D. J., Kaur, B., & Meir, E. G. V. (2003) · Frontiers in bioscience · doi:10.2741/942 · Cited by 89
Expression of hypoxia‐inducible factor 1α in tumours of patients with glioblastoma
Søndergaard, K. L., Hilton, D. A., Penney, M., Ollerenshaw, M., & Demaine, A. G. (2002) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2002.00391.x · Cited by 88
Neurobeachin Is Essential for Neuromuscular Synaptic Transmission
Su, Y., Balice‐Gordon, R. J., Hess, D. M., Landsman, D., Minarcik, J., Golden, J. A., Hurwitz, I., Liebhaber, S. A., & Cooke, N. E. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4644-03.2004 · Cited by 87
Expression of Facilitative Glucose Transporter Isoforms in Human Brain Tumors
Nagamatsu, S., Sawa, H., Wakizaka, A., & Hoshino, T. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb07441.x · Cited by 87
Said, H. M., Hagemann, C., Staab, A., Stojic, J., Kühnel, S., Vince, G. H., Flentje, M. P., Roosen, K., & Vordermark, D. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.05.003 · Cited by 86
Hypoxia in the tumorigenesis of gliomas and as a potential target for therapeutic measures
Jensen, R. L. (2006) · Neurosurgical FOCUS · doi:10.3171/foc.2006.20.4.16 · Cited by 86
Self-citationAn adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancer
Binley, K. E., Iqball, S., Kingsman, A. J., Kingsman, S. M., & Naylor, S. (1999) · Gene Therapy · doi:10.1038/sj.gt.3301001 · Cited by 85
Lund, E. L., Høg, A. M., Olsen, M. W. B., Hansen, L. T., Engelholm, S. A., & Kristjansen, P. E. G. (2004) · International Journal of Cancer · doi:10.1002/ijc.11662 · Cited by 84
Cited by
Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia
Carreau, A., Hafny‐Rahbi, B. E., Matejuk, A., Grillon, C., & Kieda, C. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01258.x · Cited by 1,246
Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma
Huse, J. T., & Holland, E. C. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2818 · Cited by 763
Bar, E. E., Lin, A., Mahairaki, V., Matsui, W., & Eberhart, C. G. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.091021 · Cited by 373
Joseph, J. V., Conroy, S., Pavlov, K., Sontakke, P., Tomar, T., Eggens-Meijer, E., Balasubramaniyan, V., Wagemakers, M., den Dunnen, W. F. A., & Kruyt, F. A. E. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.01.010 · Cited by 302
Epithelial-mesenchymal transition in glioblastoma progression
IWADATE, Y. (2016) · Oncology Letters · doi:10.3892/ol.2016.4113 · Cited by 288
Metadata
- Authors
- Jensen, R. L.
- Venue
- Journal of Neuro-Oncology
- Published
- 2009-04-09
- Volume
- 92
- Issue
- 3
- Pages
- 317-335
- ISSN
- 0167-594X (ISSN-L)
- 1573-7373
- OpenAlex
- W2055145844
- Cited by
- 287
- References
- 262
- FWCI
- 7.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.